<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 - Concepedia

Concepedia

Publication | Open Access

<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

DOI Full Paper Access

98

Citations

23

References

2021

Year

Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo, Aline de Paula Dias da Silva, Suelen da Silva Gomes Dias, Carine dos Santos da Silva, André C. Ferreira, Mayara Mattos, Camila R. R. Pão, Caroline S. de Freitas,

Journal of Antimicrobial Chemotherapy

Abstract

Daclatasvir, alone or in combination with sofosbuvir, at higher doses than used against HCV, may be further fostered as an anti-COVID-19 therapy.

References

	Year	Citations

Page 1